Risk Factors Associated with Mortality in Acinetobacter baumannii Infections: Results of a Prospective Cohort Study in a Tertiary Public Hospital in Guayaquil, Ecuador

Author:

Abarca-Coloma Luz1,Puga-Tejada Miguel2ORCID,Nuñez-Quezada Tamara3,Gómez-Cruz Otilia4,Mawyin-Muñoz Carlos1,Barungi Shivan5,Perán Macarena567ORCID

Affiliation:

1. Critical Care Unit Hospital Teodoro Maldonado Carbo, Catholic University Santiago of Guayaquil, Guayaquil 090203, Ecuador

2. Instituto Ecuatoriano de Enfermedades Digestivas (IECED), Guayaquil 090505, Ecuador

3. Department of Medical Microbiology Hospital Teodoro Maldonado Carbo, Catholic University Santiago of Guayaquil, Guayaquil 090203, Ecuador

4. Infection Prevention and Control Program, Hospital Teodoro Maldonado Carbo, Guayaquil 090203, Ecuador

5. Department of Health Sciences, University of Jaén, 23071 Jaén, Spain

6. Excellence Research Unit “Modeling Nature” (MNat), University of Granada, 18010 Granada, Spain

7. Biopathology and Regenerative Medicine Institute (IBIMER), University of Granada, 18010 Granada, Spain

Abstract

Antibiotic overuse and the resulting antimicrobial resistance pose significant global public health challenges, providing an avenue for opportunistic pathogens like Acinetobacter baumannii to thrive. This study will report the trends of Acinetobacter baumannii antimicrobial resistance patterns at the Hospital Teodoro Maldonado Carbo, Ecuador. An observational, analytical, longitudinal, and prospective study was conducted involving patients diagnosed with hospital-acquired infections. Antimicrobial susceptibility testing was performed, followed by molecular analysis of carbapenemase genes in Acinetobacter baumannii isolates. We included 180 patients aged from 16 to 93 years. The hospital mortality rate was 63/180 (35%). Invasive mechanical ventilation (IMV) was indicated in 91/180 patients (50.4%). The overall survival (OS) rate in patients on IMV was 49.5% (45/91), with a median survival of 65 days. The OS rate in patients not on IMV was 80.9% (72/89), with a median survival of 106 days (HR 2.094; 95% CI 1.174–3.737; p = 0.012). From multivariate analysis, we conclude that ventilator-associated pneumonia is the most related factor to OS.

Funder

University of Jaén

Publisher

MDPI AG

Reference39 articles.

1. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance;Magiorakos;Clin. Microbiol. Infect.,2012

2. Multidrug resistant, extensively drug resistant and pan drug resistant gram negative bacteria at a tertiary care centre in Bhubaneswar;Pattnaik;Int. J. Commun. Med. Public Health,2019

3. Excess Mortality Associated with Colistin-Tigecycline Compared with Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study*;Cheng;Crit. Care Med.,2015

4. World Health Organization (2021, July 22). Global Priority List of Antibiotics-Resistant Bacteria to Guide Research, Discovery, and Developement of New Antibiotics. Available online: https://www.who.int/en/news-room/detail/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed.

5. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: Clinical impact and therapeutic options;Kempf;Int. J. Antimicrob. Agents,2012

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3